跳至主要内容
临床试验/NCT02203409
NCT02203409Unknown不适用

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Shuguo Zheng, MD1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
Safety of the procedure defined as the incidence of postoperative complications and mortality

研究概览

简要总结

The purpose of this research is evaluate the results with laparoscopic ALPPS procedure in a single center. The validity, feasibility and limitations were assessed objectively through our clinical prospective study.The investigators expect laparoscopic ALPPS is safe, effective and feasible.

详细描述

Background: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a breakthrough in the field of hepatobiliary surgery in recent years,which stimulates the remnant liver volume(RLV) grew by 74%-87.2% in 9 to 13 days。The published literature reported that the two stages of ALPPS are the conventional laparotomy surgery,Patients need to undergo the injury of two open operations in a short time. The incidence of postoperative complications and mortality rate is as high as 53% -73% and 12%-27%.The aim of this study was to evaluate the results with laparoscopic ALPPS procedure in a single center, with special emphasis in validity, feasibility and limitations.

Results:

Clinical data include: operation time, intraoperative blood loss, volume of blood transfusion, complications and mortality, postoperative liver function, long-term curative effect and survival time were collected and analysed.

Statistical method:groups t-test ,univariate/multivariate analysis, logistic regression analysis, mixed linear regression, Cox survival analysis ,Kaplan-Meier survival analysis,Log-rank survival curves were used.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with marginally resectable or primarily non-resectable locally advanced liver tumors
  • Insufficient future liver remnant (FLR) either in volume or quality

排除标准

  • Unresectable liver metastases in the future liver remnant or unresectable extrahepatic metastases
  • Severe portal hypertension
  • High anesthesiological risk
  • Unresectable primary tumor

结局指标

主要结局

Safety of the procedure defined as the incidence of postoperative complications and mortality

时间窗: within the first 90 days after the first stage

次要结局

  • survival rate(3 years)

研究者

发起方
Shuguo Zheng, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Shuguo Zheng, MD

Professor of Hepatobiliary Surgery Institute; Chief Physician; Administrator of laparoscopic department

Southwest Hospital, China

研究点 (1)

Loading locations...

相似试验